EU and US could reach trade deal this weekend - Reuters
Investing.com - Elon Musk’s brain implant company Neuralink Corp. has joined a clinical trial studying visual prosthetics, according to information disclosed in late July on ClinicalTrials.gov, a government website that lists medical studies.
The study, sponsored by the University of California at Santa Barbara, aims "to address fundamental questions that will allow the development of a Smart Bionic Eye," according to the online description. Researchers envision an artificial intelligence-powered device that could help blind people identify faces, navigate outdoors, and read.
The trial is currently enrolling patients by invitation only, with the study description indicating that Neuralink patients will be included "once available." The specific role Neuralink will play in the research collaboration has not been clearly defined.
The research team includes collaborators from both California and Spain, working together on this visual prosthetics initiative. This marks a notable expansion of Neuralink’s clinical research activities.
The partnership represents a potential advancement in neural interface technology applications, combining Neuralink’s brain-computer interface expertise with specialized vision restoration research.
Bloomberg initially reported the news.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.